Photobiomodulation Therapy for Symptom Management in Essential Palatal Myoclonus: Two Case Studies with Long-Term Follow-Up Two Cases: 7-Year/2-Month Follow-Up
Abstract
Background: Palatal myoclonus (PM) is a rare movement disorder characterized by involuntary rhythmic contractions of the soft palate and adjacent musculature. Conventional therapies, including pharmacologic agents and botulinum toxin injections, frequently provide inconsistent or temporary relief and may be associated with adverse effects. This report evaluates photobiomodulation therapy (PBMT) as a noninvasive neuromodulatory treatment.
Cases: The two cases were managed by different clinicians in separate clinical settings under standardized protocol guidance from the primary author, allowing assessment of inter-operator reproducibility. Two patients with essential PM were treated using near-infrared diode laser PBMT. Case 1: A 26-year-old female presented with persistent PM (2.5 Hz) accompanied by dysphagia, audible clicking, and sleep disturbance. Pharmacotherapy (clonazepam and gabapentin) was discontinued due to intolerance. PBMT using a 940 nm diode laser (8.7 J/cm2) was applied over 20 sessions. Case 2: A 28-year-old male developed PM-like symptoms (3 Hz) following third molar extraction, associated with clicking, migraine, and myofascial pain. Neurological investigations were inconclusive. PBMT with a 980 nm diode laser (13.3 J/cm2) was administered over 2-month period.
Results: In Case 1, contraction frequency decreased from 2.5 Hz to 0.11 Hz after treatment and remained stable between 0.12-0.36 Hz over a 7-year follow-up, with marked improvement in swallowing and…
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.